Precigen officer plans $115K sale after option exercise
Rhea-AI Filing Summary
PRECIGEN, INC. (PGEN) is named as the issuer in a Form 144 notice filed for the planned sale of its common stock by officer Rutul Shah. The notice covers a proposed sale of 15,342 common shares, with an approximate value of $115,065.00, to be sold through Fidelity Brokerage Services LLC on or after 08/25/2026, following a stock option exercise for cash. Over the prior three months, the same person reported several additional sales of PRECIGEN common shares under Rule 144.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 15,342 shares of common stock
Approximate value of planned sale: $115,065.00
Sale on 06/29/2026: 42,924 shares for $251,105.40
+3 more
6 metrics
Planned shares to be sold
15,342 shares of common stock
Planned sale on or after 08/25/2026 under Form 144
Approximate value of planned sale
$115,065.00
Estimated gross proceeds for 15,342 shares
Sale on 06/29/2026
42,924 shares for $251,105.40
Common stock sold during past 3 months
Sale on 08/03/2026
33,772 shares for $219,518.00
Common stock sold during past 3 months
Sale on 08/06/2026
32,739 shares for $224,589.54
Common stock sold during past 3 months
Sale on 08/21/2026
34,658 shares for $259,935.00
Common stock sold during past 3 months
Key Terms
Form 144, Rule 144, Stock Option Exercise, attorney-in-fact, +1 more
5 terms
Form 144 regulatory
"144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Stock Option Exercise financial
"Common | 08/25/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
attorney-in-fact regulatory
"as attorney-in-fact for Rutul Shah"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
Fidelity Brokerage Services LLC financial
"Common | Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917"
FAQ
What does the Form 144 filing for PRECIGEN, INC. (PGEN) disclose?
It discloses that officer Rutul Shah plans to sell 15,342 shares of PRECIGEN common stock, valued at about $115,065.00, through Fidelity Brokerage Services LLC on or after 08/25/2026, in connection with a cash stock option exercise.
What total dollar amounts were reported for past PRECIGEN (PGEN) sales by Rutul Shah?
Reported gross amounts were $251,105.40 for 42,924 shares on 06/29/2026, $219,518.00 for 33,772 shares on 08/03/2026, $224,589.54 for 32,739 shares on 08/06/2026, and $259,935.00 for 34,658 shares on 08/21/2026.
What is the nature of the planned PRECIGEN (PGEN) sale in this Form 144?
The planned sale involves 15,342 shares of PRECIGEN common stock to be sold on or after 08/25/2026, described as arising from a Stock Option Exercise with consideration in cash.
AI-generated analysis. How Rhea-AI works. Not financial advice.